Nodular regenerative hyperplasia of the liver associated with didanosine persists for years even after its interruption

BMJ Case Reports

Volumn , Issue , 2011, Pages

  Hofmaenner, Daniel ^a   Kovari, Helen ^b   Weber, Achim ^b   Weishaupt, Dominik ^c   Speck, Roberto F ^b  

^a UNIVERSITY OF ZURICH   (Switzerland)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^c TRIEMLI HOSPITAL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ABACAVIR; AMINOTRANSFERASE; DIDANOSINE; EFAVIRENZ; INDINAVIR; RITONAVIR; SAQUINAVIR; STAVUDINE; ZIDOVUDINE;

ADULT; ANEMIA; ARTICLE; CASE REPORT; CD4+ T LYMPHOCYTE; CERVICAL LYMPHADENOPATHY; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG SUBSTITUTION; DRUG WITHDRAWAL; DYSPHAGIA; EPIGASTRIC PAIN; ESOPHAGUS VARICES; FEVER; HEPATOSPLENOMEGALY; HISTOPATHOLOGY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; HYPERAMYLASEMIA; LEUKOPENIA; LIVER HYPERPLASIA; MALE; MELENA; NODULAR REGENERATIVE LIVER HYPERPLASIA; NUCLEAR MAGNETIC RESONANCE IMAGING; PORTAL HYPERTENSION; PRIORITY JOURNAL; PTOSIS; THROMBOCYTOPENIA; THRUSH; WEIGHT REDUCTION;

EID: 79956263612     PISSN: None     EISSN: 1757790X     Source Type: Journal    
DOI: 10.1136/bcr.03.2011.3928     Document Type: Article

References (12)

1. Lai KK, Gang DL, Zawacki JK, et al. Fulminant hepatic failure associated with 2',3'-dideoxyinosine (ddI). Ann Intern Med 1991;115:283-4.
2. Perry CM, Noble S. Didanosine: an updated review of its use in HIV infection. Drugs 1999;58:1099-135. (Pubitemid 30055048)
3. Mallet V, Blanchard P, Verkarre V, et al. Nodular regenerative hyperplasia is a new cause of chronic liver disease in HIV-infected patients. AIDS 2007; 21 :187-92. (Pubitemid 46036926)
4. Saifee S, Joelson D, Braude J, et al. Noncirrhotic portal hypertension in patients with human immunodeficiency virus-1 infection. Clin Gastroenterol Hepatol 2008;6:1167-9.
5. Kovari H, Ledergerber B, Peter U, et al. Association of noncirrhotic portal hypertension in HIV-infected persons and antiretroviral therapy with didanosine: a nested case-control study. Clin Infect Dis 2009;49:626-35.
6. Reshamwala PA, Kleiner DE, Heller T. Nodular regenerative hyperplasia: not all nodules are created equal. Hepatology 2006;44:7-14. (Pubitemid 44049133)
7. Wanless IR. Micronodular transformation (nodular regenerative hyperplasia) of the liver: a report of 64 cases among 2,500 autopsies and a new classification of benign hepatocellular nodules. Hepatology 1990;11:787-97. (Pubitemid 20191384)
8. Casillas C, Martí-Bonmatí L, Galant J. Pseudotumoral presentation of nodular regenerative hyperplasia of the liver: imaging in five patients including MR imaging. Eur Radiol 1997;7:654-8. (Pubitemid 127723232)
9. Horita T, Tsutsumi A, Takeda T, et al. Significance of magnetic resonance imaging in the diagnosis of nodular regenerative hyperplasia of the liver complicated with systemic lupus erythematosus: a case report and review of the literature. Lupus 2002;11:193-6. (Pubitemid 34296937)
10. Rha SE, Lee MG, Lee YS, et al. Nodular regenerative hyperplasia of the liver in Budd-Chiari syndrome: CT and MR features. Abdom Imaging 2000;25:255-8. (Pubitemid 30304981)
11. Seiderer J, Zech CJ, Reinisch W, et al. A multicenter assessment of liver toxicity by MRI and biopsy in IBD patients on 6-thioguanine. J Hepatol 2005;43:303-9. (Pubitemid 40956884)
12. Seiderer J, Zech CJ, Diebold J, et al. Nodular regenerative hyperplasia: a reversible entity associated with azathioprine therapy. Eur J Gastroenterol Hepatol 2006;18:553-5. (Pubitemid 43832759)